Clinical Cardiology Alert – May 1, 2008
May 1, 2008
View Issues
-
Closure of PFO Does Not Reduce Migraine Frequency
Dowson and colleagues performed a randomized, controlled trial to assess the efficacy of PFO closure in reducing the incidence of migraine with aura. -
Value of Volume Expansion in Cardiac Tamponade
Intravascular volume expansion has long been advised as an effective temporizing technique for patients with cardiac tamponade prior to drainage of the fluid, but there is little data supporting this practice. -
Automated External Defibrillators for At-home Use
The home automatic external defibrillator trial (HAT) tested the hypothesis that placement of an automatic external defibrillator (AED) in the homes of patients with previous myocardial infarctions, who were thought to be at moderate risk for sudden death, would reduce overall mortality compared to standard measures to train family members in manual cardiopulmonary resuscitation (CPR). -
A New Drug for Rapid Conversion of Atrial Fibrillation
Vernakalant is a new investigational anti- arrhythmic drug. The compound is relatively selective, blocking the early-activating potassium channel and the frequency-dependent sodium channel. -
Ten-Year Data on AAAs
One-time screening for abdominal aortic Aneurysms (AAA) is recommended in older men, but there is little long-term data on the value of such screening, especially in women. -
Treatment of Coronary Risk Factors — Some More Good News!
Setoguchi and colleagues assessed the degree of utilization of guideline (Class I) protective drugs in elderly patients who survived an acute MI (AMI) and at least 30 days thereafter. -
Pharmacology Watch
FDA drug approval to change? Urinary incontinence in women; how metabolism of certain drugs can be predicted by genetic analysis; bowel preps may compromise renal function especially in the elderly according to a new study; FDA Actions. -
Clinical Briefs in Primary Care Supplement